[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340480-105":3,"doc-detail-340480-en":81,"detail-sidebar-cat-0-en-105":115},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","advancing-gastric-cancer-treatment-nanotechnology-innovations-and-future-prospects-review-and-future-prospects","Advancing gastric cancer treatment: nanotechnology innovations and future prospects - Review and future prospects","","Gastric cancer is a leading malignancy worldwide, with especially high incidence and mortality in Asia and China. Nanotechnology offers strong therapeutic promise, particularly via nanodrug delivery systems that improve efficacy and tumor targeting through functional modifications such as peptide targeting, tumor microenvironment responsiveness, and other delivery technologies. This review synthesizes research linking nanocarrier-based strategies to gastric cancer treatment, covering functionalized nanocarriers, multimodal combinations, and key challenges including biocompatibility, drug release control, and clinical translation to inform future clinical application directions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/advancing-gastric-cancer-treatment-nanotechnology-innovations-and-future-prospects-review-and-future-prospects/340480/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/advancing-gastric-cancer-treatment-nanotechnology-innovations-and-future-prospects-review-and-future-prospects/340480.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is gastric cancer treatment a major focus in this review?","Question",{"text":63,"@type":64},"Gastric cancer is the fifth most common cancer worldwide and is especially prevalent in Asia, with particularly high incidence and mortality rates in China.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do nanodrug delivery systems improve gastric cancer therapy?",{"text":68,"@type":64},"They enhance therapeutic efficacy and targeting through functional modifications such as targeting peptides, tumor microenvironment responsiveness, and design choices like porous silica carriers, polymer-controlled release, and lipid or carbon-based platforms.",{"name":70,"@type":61,"acceptedAnswer":71},"What limitations and challenges for nanocarriers in gastric cancer treatment does the review highlight?",{"text":72,"@type":64},"Key challenges include biocompatibility, controlling drug release, and difficulties related to clinical translation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340480,1790550732,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":33,"preview_urls":98},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Cell Biol Toxicol (2024) 40:101  \n[https://doi.org/10.1007/s10565-024-09943-9](https://doi.org/10.1007/s10565-024-09943-9)  \nAdvancing gastric cancer treatment: nanotechnology innovations and future prospects  \nTengfei Yang · Lin Guo  \nReceived: 24 June 2024 / Accepted: 4 November 2024 / Published online: 20 November 2024 © The Author(s) 2024  \nAbstract Gastric cancer (GC) is the fifth most common cancer worldwide, particularly prevalent in Asia, especially in China, where both its incidence and mortality rates are significantly high. Meanwhile, nanotechnology has demonstrated great potential in the treatment of GC. In particular, nanodrug delivery systems have improved therapeutic efficacy and targeting through various functional modifications, such as targeting peptides, tumor microenvironment responsiveness, and instrument-based methods. For instance, silica (SiO2) has excellent biocompatibility and can be used as a drug carrier, with its porous structure enhancing drug loading capacity. Polymer nanoparticles regulate drug release rates and mechanisms by altering material composition and preparation methods. Lipid nanoparticles efficiently encapsulate hydrophilic drugs and promote cellular uptake, while carbon-based nanoparticles can be used in biosensors and drug delivery. Targets such as integrins, HER2 receptors, and the tumor microenvironment have been used to improve drug efficacy in GC  \nT. Yang  \nDepartment of Health Management, Shengjing Hospital of China Medical University, Shenyang 110004,  \nP. R. China  \nL. Guo (*)  \nDepartment of General Surgery, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning Province, P. R. China  \ne-mail: [guolin@sj-hospital.org](guolin@sj-hospital.org)  \ntreatment. Nanodrug delivery techniques not only enhance drug efficacy and delivery capabilities but also selectively target tumor cells. Currently, thereis a lack of systematic summarization and synthesis regarding the relationship between nanodrug delivery systems and GC treatment, which to some extent hinders researchers and clinicians from efficiently searching for and referencing related studies, thereby reducing work efficiency. This study aims to systematically summarize the existing research on the relationship between nanodrug delivery systems and GC treatment, making it easier for professionals to search and reference, and thereby promoting further research on the role of nanodrug delivery systems and their clinical applications in GC. This review discusses the applications of functionalized nanocarriers in the treatment of GC in recent years, including surface modifications with targeted markers, the combination of phototherapy, chemotherapy, and immunotherapy, along with their advantages and challenges. It also examines the future prospects of targeted nanomaterials in GC treatment. The review particularly focuses on the combined application of nanocarriers in multiple treatment modalities, such as phototherapy, chemotherapy, and immunotherapy, demonstrating their potential in multimodal treatments. Furthermore, it thoroughly explores the specific challenges that nanocarriers face in GC treatment, such as biocompatibility, drug release control, and clinical translation issues, while providing a systematic outlook on future developments. Additionally, this study emphasizes  \nthe potential value and feasibility of nanocarriers in clinical applications, contrasting with most reviews that focus on basic research. Through these innovations, we offer new perspectives and directions for the development of nanotechnology in the treatment of GC.  \nKeywords GC · Nanotechnology · Drug delivery · Tumor microenvironment · Integrins · HER2  \nreceptors  \nOverview of research background  \nEpidemiology and stages for gastric cancer (GC) development  \nGC is the fifth most common cancer type worldwide (Cao et al. 2021 ; Abell 2023) . In Asia, particularly in China, GC’s incidence and mort","cbCaii64sXCoA0QE","https://ap.wps.com/l/cbCaii64sXCoA0QE","pdf",3290996,32,"English","# Abstract\n# Overview of research background\n## Epidemiology and stages for gastric cancer (GC) development","[{\"question\":\"Why is gastric cancer treatment a major focus in this review?\",\"answer\":\"Gastric cancer is the fifth most common cancer worldwide and is especially prevalent in Asia, with particularly high incidence and mortality rates in China.\"},{\"question\":\"How do nanodrug delivery systems improve gastric cancer therapy?\",\"answer\":\"They enhance therapeutic efficacy and targeting through functional modifications such as targeting peptides, tumor microenvironment responsiveness, and design choices like porous silica carriers, polymer-controlled release, and lipid or carbon-based platforms.\"},{\"question\":\"What limitations and challenges for nanocarriers in gastric cancer treatment does the review highlight?\",\"answer\":\"Key challenges include biocompatibility, controlling drug release, and difficulties related to clinical translation.\"}]","Advancing gastric cancer treatment: nanotechnology innovations and future prospects - Review and future prospects | PDF",1790036774,81,[99,103,107,111],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb35892d2d1dfa101a6c4ec6cfa7d211.webp",983,1324,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c279c010d0ac0087c771ef20a219422.webp",982,1322,{"page_no":30,"url":108,"width":109,"height":110},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b29cbf4bedecfcd9c3e57cf7b810cf88.webp",981,1321,{"page_no":33,"url":112,"width":113,"height":114},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4338aa1e7eb11154e525ebe23cbaff0.webp",980,1319,{"code":4,"msg":82,"data":116},[117,121,125,129,134,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":122,"show_sort_weight":123,"slug":124},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":126,"show_sort_weight":127,"slug":128},"Exam",70,"exam",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},5,"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":130,"slug":162},19,"General","general"]